GILDER GAGNON HOWE & CO LLC 13D and 13G filings for Magenta Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 06:09 am Sale | 2022-12-31 | 13G | Magenta Therapeutics, Inc. MGTA | GILDER GAGNON HOWE & CO LLC | 425,858 0.700% | -3,249,750 (-88.41%) | Filing |
| 2022-02-14 07:04 am Sale | 2021-12-31 | 13G | Magenta Therapeutics, Inc. MGTA | GILDER GAGNON HOWE & CO LLC | 3,675,608 6.300% | -542,598 (-12.86%) | Filing |
| 2021-02-16 10:04 am Purchase | 2020-12-31 | 13G | Magenta Therapeutics, Inc. MGTA | GILDER GAGNON HOWE & CO LLC | 4,218,206 8.730% | 114,781 (+2.80%) | Filing |